114 related articles for article (PubMed ID: 8903495)
21. Prognostic significance of p53 expression in relation to DNA ploidy in colorectal adenocarcinoma.
Sun XF; Carstensen JM; Stål O; Zhang H; Nilsson E; Sjödahl R; Nordenskjöld B
Virchows Arch A Pathol Anat Histopathol; 1993; 423(6):443-8. PubMed ID: 8291217
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical analysis of p53 in colorectal cancer regarding clinicopathological correlation and prognostic significance.
Tomoda H; Kakeji Y
J Surg Oncol; 1995 Feb; 58(2):125-8. PubMed ID: 7844983
[TBL] [Abstract][Full Text] [Related]
23. DNA ploidy, tumour site, and prognosis in colorectal cancer. A flow cytometric study of paraffin-embedded tissue.
Halvorsen TB; Johannesen E
Scand J Gastroenterol; 1990 Feb; 25(2):141-8. PubMed ID: 2305211
[TBL] [Abstract][Full Text] [Related]
24. Detection of p53 protein overexpression and DNA ploidy analysis in colon cancer.
Attallah AM; Elhak NG; Nasif WA; Tabll A; Ezzat F
Hepatogastroenterology; 1997; 44(18):1595-601. PubMed ID: 9427029
[TBL] [Abstract][Full Text] [Related]
25. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
[TBL] [Abstract][Full Text] [Related]
26. Systematic heterogeneity and prognostic significance of cell proliferation in colorectal cancer.
Palmqvist R; Oberg A; Bergström C; Rutegård JN; Zackrisson B; Stenling R
Br J Cancer; 1998 Mar; 77(6):917-25. PubMed ID: 9528835
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of DNA ploidy in colorectal cancer: a prospective flow cytometric study.
Jones DJ; Moore M; Schofield PF
Br J Surg; 1988 Jan; 75(1):28-33. PubMed ID: 3337945
[TBL] [Abstract][Full Text] [Related]
28. Cellular kinetics in rectal cancer.
Terry NH; Meistrich ML; Roubein LD; Lynch PM; Dubrow RA; Rich TA
Br J Cancer; 1995 Aug; 72(2):435-41. PubMed ID: 7640229
[TBL] [Abstract][Full Text] [Related]
29. [Immunochemical evidence of a mutated p53 protein expressed in human colorectal adenocarcinoma].
Hammel PR; Beuvon FX; Salmon RJ; Remvikos Y
Gastroenterol Clin Biol; 1991; 15(6-7):529-35. PubMed ID: 1916131
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
Garrity MM; Burgart LJ; Mahoney MR; Windschitl HE; Salim M; Wiesenfeld M; Krook JE; Michalak JC; Goldberg RM; O'Connell MJ; Furth AF; Sargent DJ; Murphy LM; Hill E; Riehle DL; Meyers CH; Witzig TE;
J Clin Oncol; 2004 May; 22(9):1572-82. PubMed ID: 15117979
[TBL] [Abstract][Full Text] [Related]
31. A novel immunohistochemical method to estimate cell-cycle phase distribution in archival tissue: implications for the prediction of outcome in colorectal cancer.
Scott IS; Morris LS; Bird K; Davies RJ; Vowler SL; Rushbrook SM; Marshall AE; Laskey RA; Miller R; Arends MJ; Coleman N
J Pathol; 2003 Oct; 201(2):187-97. PubMed ID: 14517835
[TBL] [Abstract][Full Text] [Related]
32. Flow cytometric analysis of DNA content and cell kinetics in colorectal carcinoma.
D'Agnano I; Cosimelli M; La Pera A; Cavaliere F; Mannella E; Giannarelli D; Cavaliere R; Zupi G
Anticancer Res; 1993; 13(3):699-703. PubMed ID: 8317899
[TBL] [Abstract][Full Text] [Related]
33. Association of ploidy and cell proliferation, Dukes' classification, and histopathological differentiation in adenocarcinomas of colon and rectum.
Wahlström B; Branehög I; Stierner U; Sunzel H; Holmberg E
Eur J Surg; 1992 Apr; 158(4):237-42; discussion 242-3. PubMed ID: 1352139
[TBL] [Abstract][Full Text] [Related]
34. Clinico-pathological correlation and prognostic significance of nuclear p53 protein in colorectal cancer. Colorectal Cancer Study Group of the University and Health Care District of Modena.
Fante R; Di Gregorio C; Losi L; Roncucci L; Ponz de Leon M
Ital J Gastroenterol; 1996 May; 28(4):205-10. PubMed ID: 8842835
[TBL] [Abstract][Full Text] [Related]
35. Correlation between [3H]thymidine and proliferating cell nuclear antigen (PCNA)/cyclin indices in archival, formaldehyde-fixed human colorectal tissues.
Bleiberg H; Morret M; Galand P
Eur J Cancer; 1993; 29A(3):400-3. PubMed ID: 8104445
[TBL] [Abstract][Full Text] [Related]
36. Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma.
Bhatavdekar JM; Patel DD; Ghosh N; Chikhlikar PR; Trivedi TI; Suthar TP; Doctor SS; Shah NG; Balar DB
Dis Colon Rectum; 1997 Jul; 40(7):785-90. PubMed ID: 9221853
[TBL] [Abstract][Full Text] [Related]
37. DNA flow cytometry, p53 levels and proliferative cell nuclear antigen in human colon dysplastic, precancerous and cancerous tissues.
Barletta A; Marzullo F; Pellecchia A; Montemurro S; Labriola A; Lomonaco R; Grammatica L; Paradiso A
Anticancer Res; 1998; 18(3A):1677-82. PubMed ID: 9673389
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of cytoplasmic p53 overexpression in colorectal cancer. An immunohistochemical analysis.
Flamini G; Curigliano G; Ratto C; Astone A; Ferretti G; Nucera P; Sofo L; Sgambato A; Boninsegna A; Crucitti F; Cittadini A
Eur J Cancer; 1996 May; 32A(5):802-6. PubMed ID: 9081357
[TBL] [Abstract][Full Text] [Related]
39. An evaluation of five different methods for estimating proliferation in human colorectal adenocarcinomas.
Wilson MS; Anderson E; Bell JC; Pearson JM; Haboubi NY; James RD; Schofield PF
Surg Oncol; 1994 Oct; 3(5):263-73. PubMed ID: 7889219
[TBL] [Abstract][Full Text] [Related]
40. Expression of c-erbB-2 and p53 in colorectal adenocarcinoma.
Sun XF; Carstensen JM; Nordenskjöld B
Anal Cell Pathol; 1995 Apr; 8(3):203-11. PubMed ID: 7547494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
